晨间信号Morning Signal
《科学》 第391卷 第6791期 · 2026年3月19日 · 中文解读

实验性瘫痪疗法在巴西引发争议

Experimental paralysis therapy sparks debate in Brazil · Luiz Felipe Fernandes
约 6 分钟News在小程序里点播,20 到 60 分钟做好
这篇讲什么
巴西脊髓损伤患者争相接受一种名为多聚层粘连蛋白的实验性注射治疗,但研究人员表示证据不足。
原文开头
Spinal cord injury patients are scrambling for access to the injection, but researchers say evidence is weak LUIZ FELIPE FERNANDES On the evening of 9 September 2025, Brazil’s leading newscast featured a story about a dramatic recovery from spinal cord injury. Bruno Drummond, 31, diagnosed with quadriplegia after a 2018 car accident, had received an experimental treatment, an injection of a compound called polylaminin, within 24 hours after the accident. Now, he was walking, descending stairs, and playfully dancing for the camera. …
摘自《科学》(Science)第391卷 第6791期 · 2026年3月19日,Luiz Felipe Fernandes。仅引用开头一小段供了解文章,版权归原刊所有,全文请阅读原刊。
晨间信号小程序码
微信扫码,在小程序里听完整版
不用登录先听一篇 · 或在微信搜索小程序 晨间信号
同期其他文章